SinoMab BioScience Statistics

Total Valuation

HKG:3681 has a market cap or net worth of HKD 1.94 billion. The enterprise value is 1.90 billion.

Market Cap	1.94B
Enterprise Value	1.90B

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:3681 has 1.39 billion shares outstanding. The number of shares has increased by 14.30% in one year.

Current Share Class	1.39B
Shares Outstanding	1.39B
Shares Change (YoY)	+14.30%
Shares Change (QoQ)	+23.89%
Owned by Insiders (%)	15.99%
Owned by Institutions (%)	0.07%
Float	896.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.43
P/TBV Ratio	3.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.25
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.86

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.67.

Current Ratio	1.91
Quick Ratio	1.85
Debt / Equity	0.67
Debt / EBITDA	n/a
Debt / FCF	-3.54
Interest Coverage	-23.16

Financial Efficiency

Return on equity (ROE) is -29.96% and return on invested capital (ROIC) is -10.52%.

Return on Equity (ROE)	-29.96%
Return on Assets (ROA)	-9.63%
Return on Invested Capital (ROIC)	-10.52%
Return on Capital Employed (ROCE)	-18.18%
Weighted Average Cost of Capital (WACC)	6.82%
Revenue Per Employee	n/a
Profits Per Employee	-1.92M
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.26% in the last 52 weeks. The beta is 0.66, so HKG:3681's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-10.26%
50-Day Moving Average	1.73
200-Day Moving Average	1.90
Relative Strength Index (RSI)	33.04
Average Volume (20 Days)	2,965,375

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-142.45M
Pretax Income	-116.83M
Net Income	-116.83M
EBITDA	-127.56M
EBIT	-142.45M
Earnings Per Share (EPS)	-0.10

Full Income Statement

Balance Sheet

The company has 419.81 million in cash and 376.68 million in debt, with a net cash position of 43.13 million or 0.03 per share.

Cash & Cash Equivalents	419.81M
Total Debt	376.68M
Net Cash	43.13M
Net Cash Per Share	0.03
Equity (Book Value)	565.17M
Book Value Per Share	0.41
Working Capital	206.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -78.43 million and capital expenditures -27.85 million, giving a free cash flow of -106.28 million.

Operating Cash Flow	-78.43M
Capital Expenditures	-27.85M
Depreciation & Amortization	17.11M
Net Borrowing	n/a
Free Cash Flow	-106.28M
FCF Per Share	-0.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:3681 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.30%
Shareholder Yield	-14.30%
Earnings Yield	-6.02%
FCF Yield	-5.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3